Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Samuel Gebhardt

3PUBLICATIONS

25CO-AUTHORS

Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Apr 15, 2026

Precision modeling of tumor antigen-specific T-cell responses in humanized mice for preclinical assessment of cancer immunotherapies.

|Aug 01, 2025

Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma.

Johannes Sam, Gabrielle Leclercq-Cohen, Samuel Gebhardt

|Mar 04, 2024

CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy.

Johannes Sam, Thomas Hofer, Christine Kuettel

Pageof 1

Frequent Collaborators

2 joint publications

Johannes Sam

2 joint publications

Sylvia Herter

2 joint publications

Christian Klein

2 joint publications

Marina Bacac

2 joint publications

Sara Colombetti

2 joint publications

Anne Schoenle

1 joint publications

Christina Claus

1 joint publications

Miro Julian Eigenmann

1 joint publications

Daniel Marbach

1 joint publications

Joana Marinho

Frequent Collaborators

2 joint publications

Johannes Sam

2 joint publications

Sylvia Herter

2 joint publications

Christian Klein

2 joint publications

Marina Bacac

Top Related Videos

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on : Dec 16, 2022

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on : May 16, 2020

See more related videos

Top Related Videos

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on : Dec 16, 2022

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on : May 16, 2020

See more related videos